What happened

Sam Kowalski's family has launched an appeal to help fund further treatment and specialist advice after a brain cancer diagnosis, the Liverpool Echo reports. Kowalski, 37, had suffered a seizure shortly before a planned holiday to Japan with his fiancée, Emily. His mother, Sahra, said she woke to missed calls from Emily and learned that Sam had been taken to Wythenshawe Hospital.S3

According to the family's account, the couple continued their trip after he was told he could fly, but dizziness and vision problems persisted. A second seizure led to a private MRI that found a brain tumour. The Echo reports that clinicians initially described it as a low-grade glioma and planned surgery.S3

Sahra said the attempted removal was stopped after movements in her son's arm and face raised concerns about neurological damage. A sample was taken instead, and the family says the biopsy identified grade 4 glioblastoma. The supplied reports do not include his medical records or a separate statement from the treating hospital.S1S2S3

Why it matters

Cancer Research UK explains that glioblastomas are fast-growing, grade 4 brain tumours. Its biopsy guidance says examination of a tissue sample can identify a tumour's type and grade and help determine treatment. That provides context for the reported change in diagnosis without independently establishing the details of Kowalski's case.R1R2S3

The family reports that a recent MRI showed no progression and slight shrinkage. The Echo also describes a ketogenic diet and exploration of red light therapy and hyperbaric oxygen. Sahra explicitly said the family did not know what had produced the improvement. The scan account cannot establish that any of those approaches caused it.S3

The background

Dietary approaches remain a subject of clinical research. The US National Cancer Institute lists a trial comparing a ketogenic diet with a usual diet alongside standard treatment for newly diagnosed glioblastoma. Its listing describes a study of possible benefit, rather than results proving effectiveness, and does not establish Kowalski's eligibility.R3

The family is also investigating tumour-treating fields, including Optune. NICE guidance says not to offer tumour-treating fields for newly diagnosed grade 4 glioblastoma. Its rationale acknowledges some clinical benefit but cites cost-effectiveness evidence against the approach. That distinction matters when describing an option outside routine care.S2S3R4R5

What happens next

The reported appeal seeks access to specialist opinions, trials and potential treatment options beyond NHS provision. It does not establish that a particular therapy has been selected or begun. The supplied account also leaves the scan date, full treatment history and fundraising target unspecified, limiting what can be concluded about the next stage of care.S2S3